Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

Conditions:   Safety Issues;   Immunogenicity Interventions:   Biological: Vi-DT Typhoid Conjugate Vaccine;   Biological: PQed Typhoid Conjugate Vaccine;   Biological: Vi Polysaccharide Vaccine Sponsor:   PT Bio Farma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials